Anzai Medical Co., Ltd.

Anzai Medical Co., Ltd. specializes in respiratory gating systems, such as the AZ-733 model, which help synchronize medical imaging with a patient’s breathing. They also produce endoscopic lighting devices, including the EZ-SCOPE AN and EZ-SCOPE LIGHT, which improve visibility during endoscopic procedures. These products are designed to assist in precise medical diagnostics and interventions.

Anzai Medical Co., Ltd. is based in the United States, which means its devices are subject to FDA regulatory requirements. The company’s products are classified under FDA categories Class I and Class II, indicating varying levels of regulatory scrutiny depending on the device’s risk profile. The FDA’s 510(k) pathway is used for regulatory submissions, ensuring compliance with U.S. medical device regulations.

Anzai Medical Co., Ltd.’s devices are listed in the FDA’s 510(k) registry, which documents premarket submissions for Class I and Class II medical devices. This registry serves as a public record of devices that have undergone FDA review and clearance, ensuring transparency and accessibility for healthcare professionals and regulators.

Anzai Medical Co., Ltd.’s devices are classified under FDA categories Class I and Class II. Class I devices generally pose the lowest risk and may require less regulatory oversight, while Class II devices involve moderate risk and require special controls to ensure safety and effectiveness. The classification determines the regulatory pathway, such as the 510(k) submission, which ensures compliance with FDA requirements.